Citigroup Inc Co Diagnostics, Inc. Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
A detailed history of Citigroup Inc transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 5,381 shares of CODX stock, worth $1,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,381
Previous 294
1730.27%
Holding current value
$1,990
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CODX
# of Institutions
38Shares Held
5.08MCall Options Held
65.5KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.73MShares$641,3000.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$437,2040.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny561KShares$207,5780.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$185,7490.0% of portfolio
-
Geode Capital Management, LLC Boston, MA320KShares$118,3960.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $12.5M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...